ROPCA
PrivateLast Round
Grant
Nov 1, 2024
Total Funding Raised
$1.39M
Company Overview
ROPCA operates in Healthcare & Life Sciences and is based in Odense. Its latest recorded funding round was a Grant round in November 2024.
ROPCA is a healthcare and robotics company that provides an AI-powered autonomous ultrasound system to assist healthcare providers with diagnosing and treating arthritis patients.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Medical AI, Industrial Robotics
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ROPCA Comparables
Compare ROPCA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Corbotics B.V. | 88% | |
| EndoCure | 84% | |
| Cobionix Corporation | 82% |
For institutional investors. Book with your work email.
ROPCA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 1, 2024 | ||||
| Grant | Jan 1, 2024 | ||||
| Seed | Aug 30, 2019 | ||||
| Grant | Apr 1, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ROPCA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Southern Denmark | Grant |
| Innovative Health Initiative | Grant |
| European Federation of Pharmaceutical Industries and Associations | Grant |
| Science Ventures Denmark | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 17, 2026
Grew 25% QoQ, from 16 to 20 employees.
- Jun 8, 2024
Grew 17% QoQ, from 18 to 21 employees.
For institutional investors. Book with your work email.
ROPCA Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ROPCA's valuation, stock price, and market status.
Is ROPCA a public or private company?
ROPCA is a private company.
What is the current stock price of ROPCA?
ROPCA is a private company, so its shares have no public market price. Caplight tracks ROPCA's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ROPCA worth (valuation)?
Valuation information for ROPCA is not publicly available.
Can I buy ROPCA stock?
ROPCA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ROPCA's last funding round?
ROPCA's most recent funding round was Grant on November 1, 2024.
Who are the main investors in ROPCA?
Key investors in ROPCA include University of Southern Denmark, Innovative Health Initiative, European Federation of Pharmaceutical Industries and Associations, Science Ventures Denmark.
Will ROPCA IPO soon?
No public IPO plans have been announced for ROPCA.
How can I track ROPCA secondary market activity?
Caplight tracks bids, offers, and trades in ROPCA's shares on secondary markets.